Generative AI Plan for Care Lab Study

April 20, 2026 updated by: Fitbit LLC

Generative AI Pre-visit Lab Study

This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

40000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • California
      • Mountain View, California, United States, 94043
        • Recruiting
        • Google LLC
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Age of majority: are of legal adult age (18 or older in most US states; 19 or older in Nebraska & Alabama, or 21 or older in Mississippi)
  2. Resides in the United States
  3. Fitbit mobile user using their Google accounts on an Android smartphone
  4. Able to read, write and willing to consent in English

Exclusion Criteria:

  1. Enrollment using a corporate google.com account
  2. Have a condition or circumstance that the investigator determines as inappropriate for participation.
  3. Have a chief complaint or symptoms that are potentially related to mental health disorders, sexually transmitted diseases or infections, or pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Arm A - Baseline
Baseline Urgency and Baseline Pre-visit Model
Other: Baseline Model
Plan for Care baseline model
Experimental: Arm B - Urgency and Pre-visit Model 1
Urgency and Pre-visit Model 1
Other: Fitbit Plan for Care Lab
A user informational tool using generative AI models
Experimental: Arm C - Urgency and Pre-visit Model 2
Urgency and Pre-visit Model 2
Other: Fitbit Plan for Care Lab
A user informational tool using generative AI models

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Self-Reported assessment
Time Frame: Day 1
Determine participants' self-reported assessment of the pre-visit experience, such as satisfaction on a likert scale
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fitbit LLC

Collaborators

Google LLC.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 21, 2025

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

April 13, 2026

First Submitted That Met QC Criteria

April 20, 2026

First Posted (Actual)

April 27, 2026

Study Record Updates

Last Update Posted (Actual)

April 27, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • GH-BMX-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe